Article
Early induction of cytokine release syndrome by rapidly generated CAR T cells in a preclinical mouse model
2022-11-12
Abstract excerpt
<h4>Summary</h4> Chimeric antigen receptor (CAR) T cells have emerged as effective strategy against B cell malignancies. Since the long manufacturing process limits patient accessability, short-term (st) CAR T cells are under investigation. Here, we evaluated CD19-CAR T cells 24 hours after exposure to lentiviral vectors. In co-culture with tumor cells and monocytes, stCAR T cells exhibited anti-tumoral activity...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a64d63af-9200-5d57-845a-83c18b7fae5a
- DOI
- 10.1101/2022.11.12.515207
